Named Patient Permission and Compassionate Use Program (CUP), 11 February 2021, Uppsala, Sweden

Named Patient Permission and Compassionate Use Program (CUP)
11 February 2021, 18.30-21.00
ONLINE in collaboration with the Medical Products Agency
This evening was an excellent opportunity to update you on what applies to Named Patient Permission (NPP/Licenser) and CUP for medicines in Sweden. Patients who have a disease that cannot be treated satisfactorily with an approved drug and who cannot be included in a clinical trial may be offered an individual license or be included in a treatment program for a group of patients called CUP.
If you missed the event, presentations now published in TOPRA in Sweden Resource Library 2020

1 Like